# Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer
Canonical URL: https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-appoints-david-sandoval-as-general-counsel-and-chief-compliance-officer
Ticker: MIST
Company: Milestone Pharmaceuticals Inc.
Source: Milestone Pharmaceuticals Inc.
Published: 2026-02-10 13:00 EST
Original Source URL: https://investors.milestonepharma.com
## Summary

New appointment strengthens executive leadership commensurate with launch of CARDAMYST™ (etripamil) nasal spray MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of David Sandoval as General Counsel and

## Article Body
New appointment strengthens executive leadership commensurate with launch of CARDAMYST™ (etripamil) nasal spray MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of David Sandoval as General Counsel and
## Recent Company News
- 2026-05-14 12:30 EST — [Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq) — Source: Milestone Pharmaceuticals Inc.
- 2026-05-13 11:11 EST — [Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-announces-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: Milestone Pharmaceuticals Inc.
- 2026-05-06 12:00 EST — [Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-announce-first-quarter-2026-financial-results-on-may-13-2026) — Source: Milestone Pharmaceuticals Inc.
- 2026-04-10 12:00 EST — [Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-announces-reset-psvt-registry-to-generate-real-world-evidence-on-cardamysttm-etripamil-nasal-spray-in-patients-with-psvt) — Source: Milestone Pharmaceuticals Inc.
- 2026-04-07 12:30 EST — [Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Milestone Pharmaceuticals Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)